Target intelligence / Profile preview

Recombination protein A (RecA) (RecA)

Target
RecA
Molecular classification
Enzyme [1, 3], ATPase [1, 6], DNA-binding protein [1, 6], Recombinase [1, 8], Nucleoprotein [1, 9]
01

Overview

Recombination protein A (RecA) is a highly conserved bacterial enzyme that plays a central role in DNA repair and homologous recombination [1, 5]. It functions by forming a helical nucleoprotein filament on single-stranded DNA, which then searches for and invades homologous double-stranded DNA to facilitate strand exchange and repair [8, 9]. In addition to its recombinase activity, RecA acts as a co-protease that triggers the bacterial SOS response by stimulating the self-cleavage of the LexA repressor [11, 12]. This induction leads to the expression of over 40 genes involved in DNA repair, survival, and stress-induced mutagenesis, which often contributes to the development of antibiotic resistance [13, 17]. Consequently, RecA is an attractive therapeutic target for the development of antibiotic adjuvants designed to sensitize pathogens to existing drugs and prevent the emergence of multi-drug resistance [2, 10]. Small molecule inhibitors and peptides targeting RecA's ATPase activity or filament formation are currently being explored to attenuate the SOS response and enhance the efficacy of DNA-damaging antibiotics like fluoroquinolones [3, 18].

Other names
RecA protein [1, 8]Bacterial recombinase A [7, 10]DNA strand exchange protein [5, 9]Recombinase A [7, 10]
02

Mechanism of action

Inhibition of RecA ATPase activity, inhibition of RecA-ssDNA nucleoprotein filament formation, and blocking of the SOS response by preventing LexA cleavage [2, 3, 10, 13].

03

Biological functions

Homologous recombination [1, 5]DNA repair [1, 6]SOS response induction [1, 11]DNA strand exchange [1, 8]Natural transformation [1]
04

Disease associations

Bacterial infection [1, 2]Antibiotic resistance [2, 10, 17]
05

Safety considerations

Potential off-target effects on human RAD51 [10, 18]Bacterial cell permeability challenges [2, 13]Increased sensitivity to environmental DNA damage [2, 15]
06

Interacting drugs

Suramin [7, 10]

5 more in the full profile.

07

Biomarkers

SOS response gene expression (e.g., sulA, recA, umuC, umuD) [13, 14, 17]LexA cleavage levels [11, 12]Bacterial mutation rates [17, 18]

Beyond the preview

Go deeper on Recombination protein A (RecA) (RecA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Recombination protein A (RecA) (RecA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call